logo
  

Stock Alert: Corvus Rise 30% On Positive Data From Early COVID Treatment Study

Shares of Corvus Pharmaceuticals, Inc. (CRVS) jumped nearly 30% on Monday morning after the drug maker reported positive results from an early stage study of investigational COVID-19 treatment.

CRVS is currently trading at $5.20, up $1.13 or 27.76%, on the Nasdaq.

The clinical-stage biopharmaceutical company said that new data from phase 1 study of CPI-006, which is intended to improve immune system by producing anti-SARS-CoV-2 antibodies, continues to support its potential as a treatment for COVID-19.

The results showed increased levels of memory B cells and memory T cells, and there have been no reports of any drug-related safety issues in any of the 15 patients treated as of September 17.

"We continue to see consistent, promising results with CPI-006 in hospitalized COVID-19 patients...We are also exploring the potential use in combination with preventative vaccines under development by third parties to enhance and prolong immunity," said Richard Miller,, president and chief executive officer of Corvus.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration is looking to set a new framework to further improve and maintain the supply of infant formula to ensure that American consumers have access to safe and nutritious infant formula. Infant formula is an essential food product that is the sole source of nutrition for many babies in the U.S. Amazon has unveiled millions of deals worldwide that will be available during its upcoming Prime Day extravaganza. The 48-hour shopping event for Prime members kicks off July 12 at 3 a.m. EDT, offering deals of up to 79% off across various categories. These include electronics, devices, toys, beauty, fashion, and home, from top national brands and small businesses. Primal Pet Foods is recalling a single lot of Raw Frozen Primal Patties for Dogs Beef Formula due to potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves lot #W10068709 of 6-pound Raw Frozen Primal Patties with best by date of 05/22/23. The Raw Frozen Primal Patties are sold in flexible packaging in the freezer at select pet stores.
Follow RTT